On 11/14/23, Tandem Diabetes Care Inc (NASDAQ: TNDM) stock enjoyed a major increase of 19.0%, closing at $17.82. The stock has risen 16.4% during the last week but has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be in line with the cost of capital, TNDM is expected to be Value Creation neutral.
Tandem Diabetes Care has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Tandem Diabetes Care has a very low Appreciation Score of 13 and a very low Power Rating of 0, triggering the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment